Correlation of Inhibin A Serum Level with Preeclampsia by Pratama, Dian
Research Report
Correlation of Inhibin A Serum Level with Preeclampsia
Hubungan antara Kadar Inhibin A Serum dengan Preeklampsia
Dian Pratama, Jusuf S. Effendi, Anita D. Anwar
Department of Obstetrics and Gynecology
Medical Faculty of Padjadjaran University/
Dr. Hasan Sadikin Hospital
Bandung
INTRODUCTION
Preeclampsia is a pregnancy complication syndrome
marked by blood pressure increment and proteinurine
in a pregnant woman that never has any history of
hypertension. Usualy this syndrome appears in late
2nd trimester to early 3rd trimester of pregnancy and
diminishes or disappears after birth.1,2
Preeclampsia incidence in multiparity varies but
still lower than nulliparity. It is highly influenced by
parity, ethnic, race, and genetical predisposition.2 In
Asia, preeclampsia incidence varies, in Burma, China,
Thailand and Vietnam is around 0.4 - 4.9%, Singapore
is a 0.13 - 6.66%. Indonesia’s incidence Of pree-
clampsia approximately 3.4 - 8.5% of all pregnancy.3
According to Padjadjaran University Faculty of Medi-
cine Obstetrics and Gynecology department’s annual
reports from 2007 - 2009 in Hasan Sadikin Hospital,
the incidence of mild preeclampsia is 0.97 - 2.08%,
while severe preeclampsia rates to 1.33 - 2.94%.4-6
Eclampsia is one of preeclampsia complications
that causes maternal morbidity and mortality. Mater-
nal mortality rate due to eclampsia in USA is 1 in
2000 to 3000 pregnancies, while in developing coun-
tries is 1 in 100 to 1700 pregnancies.7
The preeclampsia pathophysiology theory that is
believed until now is 2 phase theory of preeclampsia
by placenta as the trigger. It is begun at 1st phase of
failed trophoblast invasion to maternal spiral arteries
which than continues to 2nd phase of clinical syn-
drome of hypertension and proteinurine. In a normal
process of implantation, the trophoblasts invasion of
maternal spiral arteries continues to a remodeling
process. The trophoblastic cells replace the endothe-
lial and muscular layer of arteries so it would dilate
the arteries’ diameter. In preeclampsia, abnormal shal-
low process of trophoblast invasion occurs, causes the
more profound myometrial arteries not losing the en-
Abstract
Objective: The purpose of this research is to analyze the differ-
ence of Inhibin A serum level between preeclampsia patients with
normal pregnant patients and to analyze the relation between Inhibin
A serum level with preeclampsia.
Method: Comparison of average Inhibin A serum level of the
preeclampsia group with normal pregnancy was analyzed by using
Mann-Whitney test, and the correlation between Inhibin A serum
level and preeclampsia was using biserial point correlation test.
Samples were obtained from blood of patient suffered preeclampsia
and also normal pregnancy, each containing 17 samples according
inclusion and exclusion criterias. Patients came to Hasan Sadikin
Hospital and two satellite hospitals in August to November 2010.
Result: Characteristic test in two groups of study showed that
both groups were homogeny and could compared. Mean level of In-
hibin A serum was higher in preeclampsia (1268.08 pg/ml) than nor-
mal pregnancy (911.12 pg/ml) (p = 0.042) there was a strong posi-
tive correlation between Inhibin A serum level with preeclampsia (r
pbi = 0.354; p = 0.027).
Conclusion: From this research, we can conclude that Inhibin A
serum level in preeclampsia is higher than normal. There is a posi-
tive correlation of Inhibin A serum level with preeclampsia. 
[Indones J Obstet Gynecol 2011; 35-1: 36-9]
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Abstrak
Tujuan: Tujuan penelitian ini adalah menganalisis perbedaan
kadar Inhibin A serum pada penderita preeklampsia dengan ke-
hamilan normal dan menganalisis hubungan antara kadar Inhibin
A serum dengan preeklampsia.
Metode: Perbandingan rerata kadar Inhibin A serum kelompok
preeklampsia dengan kehamilan normal menggunakan uji Mann-
Whitney, dan korelasi antara kadar Inhibin A serum dengan pre-
eklampsia menggunakan uji korelasi point biserial. Sampel diper-
oleh dari darah pasien preeklampsia dan kehamilan normal dengan
masing-masing sebesar 17 sampel sesuai dengan kriteria inklusi
dan eksklusi. Subjek penelitian datang ke RS Dr. Hasan Sadikin
Bandung dan dua rumah sakit jejaring periode Agustus sampai
November 2010.
Hasil: Uji karakteristik pada kedua kelompok penelitian menun-
jukkan kedua kelompok homogen dan dapat diperbandingkan. Re-
rata kadar Inhibin A serum pada preeklampsia lebih tinggi (1268,08
pg/ml) dibandingkan dengan kehamilan normal (911,12 pg/ml) (p =
0,042). Terdapat korelasi positif antara kadar Inhibin A serum de-
ngan preeklampsia (r pbi = 0,354; p = 0,027).
Kesimpulan: Pada penelitian ini dapat disimpulkan bahwa ka-
dar Inhibin A serum pada preeklampsia lebih tinggi dari kehamilan
normal. Terdapat hubungan positif antara kadar Inhibin A serum
dengan preeklampsia
[Maj Obstet Ginekol Indones 2011; 35-1: 36-9]
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dothel and muscular layers, and therefore only few
parts of arteries that dilate compare to normal dilata-
tion.2
The cellular mechanism of implantation and tro-
phoblast invasion processes are so complex that until
now it is not fully understood yet. Multiple factors
participate in such process e.g. growth factors, peptide
hormones, steroid hormones, cytokines and immune
factors. One of the growth factors is Inhibin A. In-
hibin A is a dimeric glycoprotein originates from
transforming growth factor ß superfamily, consists of
αßA (Inhibin A) dan αßB (Inhibin B), synthesized by
anterior hypophysial gland, granulose cell and other
tissues as well. In early pregnancy it is produced by
corpus luteum and then produced by placenta espe-
cially by cytotrophoblasts. Inhibin A is known as a
FSH-releasing hormone regulator, but recent evi-
dences demonstrate an important local action of In-
hibin A especially as a paracrine regulator in repro-
duction function. Other growth factor include in
transforming growth factor ß superfamily is Activin.
It serves as a modulator of cellular proliferation and
differentiation, apoptosis of tissue remodeling and in
inflammation. Local function of Inhibin A is unknown
yet, and the synthesis of subunit a is limited to endo-
crine organs.8
Inhibin A and Activin are expressed widely in en-
dometrium, especially have a role in implantation pre-
paration and decidualization of endometrial stroma.
During the decidual invasion process by trophoblasts,
the existence of Inhibin A, Activin and other growth
hormones can be detected at 7 - 8 days of pregnancy.
Activin and Inhibin A have opposite properties, Ac-
tivin supports this process, while Inhibin A and ma-
crophage inhibitory cytokine-1 (MIC-1) inhibit the
process. In trophoblasts invasion failure of preeclamp-
sia hypoxia would occur at the surface of syncitiot-
rophoblast. This then will provoke repair response by
cytotrophoblast by stimulating the secretion of arterial
growth factors of angiogenic protein such as Vascular
Endotehelial growth factor (VEGF), Placental growth
factor (PLGF), dan Transforming growth factor ß
(TGF-ß) which consists of Inhibin A. The increment
of Inhibin A serum in preeclampsia can be detected
from 10 weeks of gestational age that exceeds normal
pregnancy level.9-11
In researches conducted by experts of preeclamp-
sia, controversial results are still the issue regarding
the Inhibin A serum in relation to trophoblast invasion
disturbance as etiology of preeclampsia. Phupong12,
Muttukhrisna13, and Palwattananupant14 explain in
their research that there is appositive relation of In-
hibin A serum level with trophoblast invasion distur-
bance in preeclampsia. In other research conducted
by Raty15 and Emma16 no relation was found. So,
from the previous explanation, to add justification of
the preliminary research, researcher feels the neces-
sity to conduct a research to prove the difference
among those results. This research is purposed to ana-
lyze the difference between Inhibin A serum level in
preeclampsia compared to normal pregnancy and to
analyze the relation between Inhibin A serum level
with preeclampsia. The measurement technique of In-
hibin A in this research is done by ELISA.
METHOD
The method used in this research is cross sectional
study with correlation analysis. Comparison of mean
concentrations of serum Inhibin A between group of
pre-eclampsia with normal pregnancies using the
Mann-Whitney test, and correlation between Inhibin
A serum levels with severity of preeclampsia using
biserial point correlation test. Selection of study sub-
jects were determined by consecutive sampling.
RESULTS
This research was conducted from August 2010 until
November 2010. During that period it was obtained
34 research subjects who fulfilled the inclusion crite-
rias, which consisted of 17 subjects aged ≥ 28 weeks
pregnant women with preeclampsia and 17 normal
pregnant subjects aged ≥ 28 weeks as the control
group. Study subjects were from patients who come
to the outpatient clinic of Obstetrics and Gynecologic
RS Dr. Hasan Sadikin, RS dr. Slamet Garut, and
RSUD Sumedang. Both groups were performed a
blood sampling to check levels of Inhibin A in the
Prodia Laboratory Jakarta.
All study subjects were assessed for baseline ex-
amination that included age, parity, and gestational
age. Results shown in the tables below.
Table 1. Subject Characteristics.
Charac-
teristics
Research Group
Total StatisticTestPreeclamp-
sia (n=17)
Normal
(n=17)
Age (year)
< 25  2  6  8 t = 1.991
25 - 34 10  8 18 p = 0.055
> 35  5  3  8
Mean (± SD) 31.5 (5.7) 27.1 (7.1)
Range 20 - 40 16 - 43
Parity
0  8  8 χ2 = 0.0
1 - 3  9  9 p = 1.0
Gestational
Age (week)
< 37  8  4
37 - 41  9 13 Zmw = 0.332
Mean (± SD) 35.8 (4.0) 36.5 (2.9) p = 0.760
Range 28 - 41 30 - 39
Note: χ2 = Chi-Square; t = t test; p = 0.05 significant
Table 1 shows that the mean age of mothers in
both groups showed no significant difference (p =
0.055). In preeclampsia group, maternal age range
was 20 - 40 years and in the normal pregnancy group
the maternal age range is 16 - 43 years. Similarly,
parity showed no significant difference (p = 1.0). The
mean gestational age between the two groups have
value of p = 0.760. Thus, these two groups were ho-
mogeneous so that proper studies can be compared.
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Table 2 presents comparative data on mean con-
centrations of Inhibin A between preeclampsia and
normal pregnancy group. Using Mann-Whitney test,
levels of Inhibin A in preeclampsia group was higher
(1268.08 pg/ml) when compared with normal preg-
nancy group (911.12 pg/ml). Range Inhibin A serum
levels in preeclampsia group is 453.2 to 1900 pg/ml
and in normal pregnancy group is 131.3 to 1609.3
pg/ml with significant statistical value (p = 0.042). It
can be concluded that serum levels of Inhibin A was
higher in preeclampsia compared with normal preg-
nancies.
Table 2 shows that there is a significant correlation
between levels of Inhibin A serum with the incidence
of preeclampsia (p = 0.027) with the positive biserial
point correlation (r pbi = 0.354).
Table 3. Correlation between levels of Inhibin A serum and
degree of preeclampsia.
Inhibin A
(pg/ml)
Preeclampsia
Mild (n = 4) Severe (n = 13)
Mean (± SD) 546.2 (78.9) 1239.4 (578.5)
Median 545.6 1321.2
Range 453.2 - 636.3 57 - 1900
Note: r pbi = 0.486; p = 0.048
Table 3 shows that there is a significant correlation
between levels of Inhibin A serum with a degree of
preeclampsia (p = 0.048) with positive correlation
(r pbi = 0.486).
DISCUSSION
Subjects Characteristics
The frequency of preeclampsia for each country vary
due to many factors such as primigravida, socio-eco-
nomic status, the difference criteria in determining the
diagnosis, and others. In primigravida, the frequency
of preeclampsia was higher compared with multi-
gravida, especially the young primigravida. Diabetes
mellitus, hydatidiform mole, multiple pregnancy, hy-
drops fetalis, age more than 35 years, and obesity are
predisposing factors for preeclampsia.17
Gestational age is very influential in the clinical
course of preeclampsia. Dekker and Sibai found that
began early second trimester of pregnancy or gesta-
tional age more than 12 weeks, pregnant women who
are destined to develop preeclampsia showed a sig-
nificant decrease of T helper cells compared with
women with normal blood pressure.2 Another study
conducted by Bardeguez et al found that the occur-
rence of an increase in the formation of antibodies on
endothelial cells that are found in more than 50 per-
cent of women was in line with the increasing age of
preeclampsia.2 On the basis of statistical analysis on
the characteristics of the three variables of research
subjects, the two research groups are homogeneous
so that it can be compared.
Comparison of Mean Levels of Inhibin
Result from the above line are consistent with pre-
vious research that has been done by Muttukrishna et
al, who studied the levels of Inhibin A in 20 women
with preeclampsia and 20 women with normal preg-
nancies. Inhibin A levels were significantly increased
in serum preeclampsia.18 Phupong found that levels
of Inhibin A is greater in the preeclampsia group than
the normal pregnancy.12 According to Rohra et al, se-
rum levels of Inhibin A in preeclampsia was 10 times
higher than in normal pregnancy.10 Research con-
ducted by Khalil A, et al showed that the serum levels
of Inhibin A detected in normal pregnant women was
1.26 ± 0.32 pg/ml, whereas the levels found in pree-
clampsia was 2.69 ± 1,41 pg/ml.19 Palwattananupant
and Phupong in their research concluded that serum
levels of Inhibin A in preeclampsia was greater
(1229.7 ± 537.5 pg/ml) compared with normal preg-
nancies (839.1 ± 370.0 pg/ml).14 Therefore, we can
conclude that the result of this study support the hy-
pothesis that there are increased serum levels of In-
hibin A in preeclampsia when compared with normal
pregnancy.
Relationship between Serum Levels of Inhibin A
in Degree of Preeclampsia
The results above are consistent with the study con-
ducted by Zeeman et al in 2000, that measure levels
of Inhibin A from all the women who were treated at
Parkland Hospital for evaluation of pregnancy in-
duced hypertension. In that study found levels of In-
hibin A was greater than 3196 pg/ml. That high levels
of Inhibin A was found in the group of women with
severe preeclampsia. Inhibin A levels significantly
correlated with the degree of hypertension in preg-
nancy. Specifically, using normal pregnancies as con-
trol group, Zeeman et al concluded that the levels of
Inhibin A increased significantly in severe preeclamp-
sia.20
Table 2. Comparison of mean Inhibin A concentration between preeclampsia and normal pregnancy groups.
Variable
Research Group
Statistic
TestPreeclampsia
(n = 17) (pg/ml)
Normal Pregnancy
(n = 17) (pg/ml)
Inhibin A Concentration:
Mean (SD) 1268.08 (510.68) 911.12 (497.66) t = 1.802
Median 1380.6 973.15 p = 0.042
Range 453.2 - 1900 131.3 - 1609.3
Note: ZM-W (Mann-Whitney test (p = 0.042); biserial point correlation (r pbi = 0.354; p = 0.027)
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CONCLUSION
Inhibin A serum levels higher in patients with pree-
clampsia compared with normal pregnancies and there
is a positive relationship between levels of Inhibin A
serum with preeclampsia.
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